Detailed price information for Beta Bionics Inc (BBNX-Q) from The Globe and Mail including charting and trades.
The company's Biomea that is the lead program, icovamenib, is the first in the category of menin inhibitors directed to the treatment of both type 1 and type 2 diabetes that holds the potential to ...
Background Cardiac sarcoidosis (CS) creates complex treatment challenges, especially for patients who fail to respond to ...
SUPER-1 evaluated GZR4 in insulin-naïve Chinese adults with T2DM, while SUPER-2 assessed those previously treated with basal insulin.
Global hepatitis B treatment efforts are at a turning point. Major treatment guidelines have been updated in the past few years, including from the Chinese Society of Hepatology and Chinese Society of ...
New FDA approvals and emerging trial data drive two pivotal 2026 NCCN guideline updates: lutetium-177 PSMA-617 for ...
Risankizumab, guselkumab, and ustekinumab were associated with the lowest risk for progression from psoriasis to psoriatic arthritis.
ETHealthworld.com brings latest fatty liver news, views and updates from all top sources for the Indian Health industry.
The GLP-1 era has reshaped obesity treatment by validating gut–brain pharmacology as a scalable, clinically meaningful approach. Yet obesity remains a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results